These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38972518)

  • 1. Exploring the influence of hydrogen bond donor groups on the microstructure and intermolecular interactions of amorphous solid dispersions containing diflunisal structural analogues.
    Cools L; Derveaux E; Reniers F; Dehaen W; Adriaensens P; Van den Mooter G
    Int J Pharm; 2024 Aug; 661():124438. PubMed ID: 38972518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K; Delaney S; Zhang GGZ; Munson EJ
    Mol Pharm; 2019 Dec; 16(12):4836-4851. PubMed ID: 31682129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Drug-Polymer Intermolecular Interactions on Dissolution Performance of Copovidone-Based Amorphous Solid Dispersions.
    Que C; Deac A; Zemlyanov DY; Qi Q; Indulkar AS; Gao Y; Zhang GGZ; Taylor LS
    Mol Pharm; 2021 Sep; 18(9):3496-3508. PubMed ID: 34319746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17O solid-state NMR as a sensitive probe of hydrogen bonding in crystalline and amorphous solid forms of diflunisal.
    Vogt FG; Yin H; Forcino RG; Wu L
    Mol Pharm; 2013 Sep; 10(9):3433-46. PubMed ID: 23822557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
    Giannachi C; Allen E; Egan G; Vucen S; Crean A
    Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hydrogen bonding between different crystallization tendency drugs and PVPVA on the stability of amorphous solid dispersions.
    Wu J; Mooter GVD
    Int J Pharm; 2023 Nov; 646():123440. PubMed ID: 37742824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
    Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
    Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.
    Yuan X; Xiang TX; Anderson BD; Munson EJ
    Mol Pharm; 2015 Dec; 12(12):4518-28. PubMed ID: 26512737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Polymer Interactions in Acetaminophen/Hydroxypropylmethylcellulose Acetyl Succinate Amorphous Solid Dispersions Revealed by Multidimensional Multinuclear Solid-State NMR Spectroscopy.
    Pugliese A; Toresco M; McNamara D; Iuga D; Abraham A; Tobyn M; Hawarden LE; Blanc F
    Mol Pharm; 2021 Sep; 18(9):3519-3531. PubMed ID: 34375100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using
    Shi C; Li L; Zhang GGZ; Borchardt TB
    Mol Pharm; 2019 Nov; 16(11):4751-4754. PubMed ID: 31553871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
    Pugliese A; Tobyn M; Hawarden LE; Abraham A; Blanc F
    Mol Pharm; 2022 Nov; 19(11):3685-3699. PubMed ID: 36037249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.